RNA-based enabling technologies and therapies
- Galsomes
- Formulation of lipid nanoparticles for mRNA and adjuvant delivery to antigen presenting cells
- Autologous tumor-derived RNA-loaded dendritic cell vaccine
- Improved cellular delivery of siRNA and related macromolecular therapies
- mRNA production service facility - contact Prof. Niek Sanders
Also see the page on nanodelivery technology to discover targeting options for RNA